相关实验视频

Updated: Jan 17, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

在接受全基性HSCT的儿科骨髓性恶性瘤中进行调节方案:一个比较的单中心研究

Andra D Marcu^1,2, Cristina G Jercan^1,2, Ana M Bica^1,2

¹Faculty of Medicine, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.

Frontiers in oncology

|September 19, 2025

概括

降低毒性调节 (RTC) 对接受干细胞移植的儿科骨髓性恶性瘤有希望,平衡有效性和毒性. 这种方法可能会改善结果,特别是基于克洛法拉宾的疗法.

科学领域:

血液学血液学血液学
儿科瘤学儿科瘤学
移植免疫学移植免疫学

背景情况:

对于接受全源造血干细胞移植 (HSCT) 的儿科骨髓性恶性瘤的最佳调节方案仍在争论中.
通过比较肌肉衰变条件 (MAC),降低毒性条件 (RTC) 和降低强度条件 (RIC),改善患者的治疗结果至关重要.

研究的目的:

为了比较MAC,RTC和RIC的疗效和毒性,在接受HSCT的小儿病患者中进行骨髓性恶性瘤治疗.
为了评估移植与宿主疾病 (GvHD),复发率,存活率和死亡率原因在不同的调节方案.

主要方法:

对59名患有骨髓瘤恶性瘤的儿科患者进行了回顾性分析,接受了HSCT.
对MAC,RTC和RIC进行比较,对基于fludarabine和clofarabine的RTC疗法进行亚组分析.
评估主要终点,包括GvHD,复发,整体存活率 (OS),无病存活率 (DFS) 和死亡率,以及二次终点,如并发症和移植动力学.

主要成果:

与MAC和RIC相比,RTC的输血需求显著降低,血小板移植速度更快,住院时间更短.
虽然在RTC和RIC中病毒再激活更频繁,但RTC显示出更有效的病毒控制,包括CMV清除.
一年后的OS和DFS是可比的,但RTC显示了更高的OS趋势;基于克洛法拉宾的RTC疗法表明了更好的OS和减少GvHD和复发相关死亡率.

结论:

对于儿科骨髓瘤恶性瘤,建议采用个性化调节策略.
对于接受HSCT的选定儿科患者来说,RTC似乎是一种平衡的方法,可降低毒性和潜在的改善结果.
基于克洛法拉宾的RTC疗法显示有望提高这一患者群体的存活率和减少并发症.

关键词:

这是一个比较的比较.条件调节方案的调节方案.造血干细胞移植造血干细胞移植骨髓化物骨髓化物儿科儿科儿科

更多相关视频

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...